Ticagrelor Teva

Ticagrelor Teva is an antiplatelet medication used to prevent blood clots in patients with heart conditions. It belongs to the P2Y12 inhibitor class and is taken orally. This generic version is manufactured by Teva B.V. in the EU.

Ticagrelor Teva is primarily used to reduce the risk of heart attack or stroke in people with a history of heart problems, such as those who have undergone stent placement. It works by preventing blood platelets from clumping together, which can block arteries. This medication is often prescribed alongside low-dose aspirin for enhanced effectiveness in preventing cardiovascular events.

Ticagrelor Teva helps maintain healthy blood flow by reducing the likelihood of blood clots forming in the arteries. Users may notice improved circulation and a reduced risk of chest pain or other heart-related symptoms. Some individuals report mild effects like shortness of breath or dizziness, which are typically temporary.

Ticagrelor Teva should be taken exactly as prescribed by a healthcare provider. It is important to inform your doctor about any bleeding disorders or upcoming surgeries, as this medication affects blood clotting. Avoid activities that may increase the risk of bleeding, such as contact sports or using sharp objects.

Ticagrelor Teva can interact with other medications that affect blood clotting, such as warfarin or nonsteroidal anti-inflammatory drugs (NSAIDs). It may also interact with strong CYP3A4 inhibitors or inducers, such as certain antifungals or anticonvulsants. Alcohol use should be limited, as it may increase the risk of side effects like bleeding.